1. PFE:NYQ

    Pfizer Inc

    USD

    29.93

    Today's change

    0.01 / +0.03%

    1 year change

    +4.25%

    As of Sep 16 2014 16:43 BST. Data delayed by at least 15 minutes.

Search for Pfizer Inc and
  1. September 15, 2014

    Takeover Panel proposes tougher rules for deal promises

    The body that polices UK dealmaking has proposed strengthening its governing Takeover Code to address promises made during...

  2. September 11, 2014

    Pfizer says ‘window still open’ for tax inversions

    Pfizer says the window is still open for US companies to use transatlantic deals to lower their tax rates despite President...

Special Reports

  1. Combating Tuberculosis

    The emergence of deadly new drug-resistant strains of TB threatens to unravel years of...
  2. Doing Business in Wallonia

    Wallonia, the French-speaking region of Belgium, is rethinking an economy traditionall...
Search more Special Reports on this topic.

  1. August 29, 2014

    AstraZeneca gains on renewed bid chatter

    AstraZeneca was among the FTSE 100 leaders on Friday as bid chatter continued to prod the drug company’s shares higher. The...

  2. August 28, 2014

    Douglas Carswell in quotes

    Tory MP Douglas Carswell, who defected to the anti-Brussels, anti-immigration UK Independence party on Thursday, is a...

  3. August 24, 2014

    Pfizer weighs options on AstraZeneca bid

    Pfizer is considering its acquisition options as a potential path opens this week for the US drugmaker to renew its pursuit...

  4. August 21, 2014

    Drugmaker link-up puts Astra on top

    The UK’s two biggest drugmakers both made it on to the FTSE 100 leaderboard after AstraZeneca developed a partnership that...

  5. August 6, 2014

    Pharma shares slide on fears of ‘tax inversion’ clampdown

    Investors fled global healthcare stocks on Wednesday after the Obama administration threatened action to halt the wave of...

  6. August 4, 2014

    AstraZeneca chairman Leif Johansson defends Pfizer rebuff

    Leif Johansson wants to set something straight: he does not want to be prime minister of Sweden. This was just one of the...

  7. August 1, 2014

    GlaxoSmithKline vulnerable to Pfizer bid after price slump

    GlaxoSmithKline’s fall to an 18-month low might make the drugmaker vulnerable, according to Berenberg analysts. A 20 per...

  8. July 31, 2014

    AstraZeneca raises full-year earnings guidance

    AstraZeneca raised its full-year earnings guidance on Thursday as Pascal Soriot, chief executive, declared “significant...

  9. July 30, 2014

    AstraZeneca to bolster respiratory drugs with Almirall deal

    AstraZeneca has bought a range of respiratory drugs from Almirall of Spain for up to $2.1bn in its biggest deal since...

  10. FT Alphaville

    July 29, 2014

    The Closer

    FURTHER FURTHER READING - FT editorial on Russia and sanctions. - Math + statistics = great beach reading. - Why the...

  11. July 29, 2014

    Pfizer refuses to rule out tax inversion deals

    Pfizer has called for “fundamental reform” of the US tax system – but said it was still interested in acquisitions that...

  12. July 18, 2014

    Technology: Wear your medicine

    Walter de Brouwer’s life changed when his son fell 35 feet from a window. Spending anxious months in intensive care, the...

  13. July 14, 2014

    AbbVie closes in on £31bn takeover of Shire

    AbbVie is closing in on a £31bn takeover of Shire in what would be the latest example of a US company buying a European...

  14. July 13, 2014

    Vince Cable plans to toughen up takeover rules

    Vince Cable plans to strengthen Britain’s takeover rules to make it harder for international bidders to renege on promises...

  15. July 8, 2014

    Cable backtracks on move to protect science industry

    Vince Cable has signalled the coalition will resist the Labour party’s demands for stronger government powers to intervene...

  16. July 8, 2014

    AbbVie avoids Pfizer errors in bear hug against Shire

    My pals are bigger than your pals. AbbVie has resorted to an old playground intimidation tactic, by implying a majority of...

  17. July 6, 2014

    Science parks’ role as innovation centres ‘under threat’

    The chairman of the UK Science Park Association has warned that their role as centres for business innovation is under...

  18. July 1, 2014

    AstraZeneca chief increases stake in drugmaker

    AstraZeneca’s chief executive has signalled his confidence in the company’s prospects by buying £2m worth of its shares,...

  19. June 29, 2014

    Green chemistry: Pharmaceutical companies try to clean up their act

    Pharmaceutical companies tend to highlight their role in saving lives, but say little about the impact their manufacturing...

  20. Business Blog

    June 27, 2014

    Defensive play in the World Cup of corporate taxation

    The global system for taxing multinational companies is broken, but no country wants to alter it too radically for fear of...

  21. June 20, 2014

    AstraZeneca set to bolster takeover defences

    AstraZeneca is considering selling the rights to some of its future revenues in a move that would boost the UK drugmaker’s...

  22. June 17, 2014

    Major pharmaceutical groups may be too big to succeed

    As Pfizer eyed a £70bn takeover of AstraZeneca this spring, the prospective deal highlighted an awkward truth for the chief...

  23. June 16, 2014

    Medtronic / Covidien: tax and save

    The news release did not mention tax benefits. The fact that the combined company would be Irish came two-thirds of the way...

  24. June 12, 2014

    Taxing time ahead as offshore rules come under more scrutiny

    ‘Golden age’ for offshore cash The OECD called it “the golden age” of tax planning: a period in which multinational...

  25. June 11, 2014

    A new approach is needed for British dealmaking

    Many countries have liberalised their takeover regimes in the past three decades. Thanks to this and the impact of...

  26. June 8, 2014

    Hostile takeovers rise to 14-year high in M&A as confidence grows

    Hostile takeover offers are making up the greatest proportion of global deal activity in 14 years as resurgent economic...

  27. MBA blog

    June 4, 2014

    The siren song of innovation revisited

    The last few weeks have been busy with learning all about mergers and acquisitions and international finance as a part of my...

  28. June 3, 2014

    AstraZeneca seeks to bring new cancer drugs to market

    AstraZeneca claims to have demonstrated the potential “to transform the way cancer is treated” as it steps up efforts to...

  29. June 3, 2014

    Loan caps too weak to curb runaway London prices

    The correlation between proliferating property porn and rising London house prices cannot have escaped the notice of Royal...

  30. June 2, 2014

    Shire: fever pitch

    The mergers and acquisitions rumour mill has been grinding at Shire for ages. Every possible deal, one would think, has been...

  31. June 1, 2014

    AstraZeneca chief questions linking his pay to £55 share target

    AstraZeneca’s chief executive has questioned calls for his pay to be linked to achieving the £55 share price that was...

  32. June 1, 2014

    Beneficial owners suffer from ‘democratic deficit’

    Pharmaceutical company Pfizer’s proposed £69bn takeover of UK rival AstraZeneca may have come to an end, for now at least,...

  33. May 30, 2014

    Corporate citizens of the world owe fealty to us all

    The head of a British multinational declared this week that he opposed the idea of companies that exist “somewhere in the...

  34. May 30, 2014

    Hopes for cancer cures offer comfort for battered pharma

    It is the Holy Grail of medical science. Ever since Hippocrates, the Greek physician, first described the disease more than...

  35. May 30, 2014

    AstraZeneca’s resistance efforts rely on cancer drug advances

    After spending weeks defending itself against a near-£70bn takeover approach from Pfizer, AstraZeneca hopes data to be...

  36. May 29, 2014

    UK lesson for Stryker and Pfizer

    Twice in two weeks, US companies interested in buying UK groups have walked away after coming up against British takeover...

  37. May 29, 2014

    GlaxoSmithKline asks for bids on older drugs list

    GlaxoSmithKline has invited private equity firms to bid for some of its older drugs in the latest step by Sir Andrew Witty,...

  38. May 28, 2014

    The regulators were right to force Pfizer’s hand

    Pfizer has announced that it will not, after all, be making an offer for AstraZeneca. By contrast, four years ago another...

Search for Pfizer Inc and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. Lex on the rejection of Pfizer's ‘final’ bid...
    May 19, 2014

    Lex on the rejection of Pfizer's ‘final’ bid

  2. The FT debates Pfizer's takeover bid for AstraZeneca...
    May 13, 2014

    The FT debates Pfizer's takeover bid for AstraZeneca